期刊文献+

恶性疟原虫主要裂殖子表面蛋白1C末端片段在毕赤酵母表达系统的高效表达与纯化(英文) 被引量:3

High level expression and purification of 1 C-terminal fragment of merozoite surface protein of Plasmodium falciparum in Pichia pastoris
下载PDF
导出
摘要 目的利用毕赤酵母表达系统高效表达并获得纯度较为理想的恶性疟原虫主要裂殖子表面蛋白1 C末端片段(MSP-119)重组蛋白。方法将带有6-his基因的MSP-119基因序列插入毕赤酵母分泌型表达载体pPIC9k中,用高压电穿孔转化法将目的基因转化入酵母感受态细胞GS115,筛选出高拷贝转化子,优化表达条件,利用甲醇进行诱导表达。表达产物用SDS-PAGE和免疫印迹进行检测。结果毕赤酵母分泌表达MSP-119蛋白,免疫印迹结果表明MSP-119基因表达蛋白能被抗MSP-119的单抗所识别,出现特异条带,将培养上清利用Ni-NTA柱纯化后,推算MSP-119蛋白的表达量为1.0g/L。结论酵母细胞表达系统可高效表达可免疫识别的MSP-119重组蛋白。 To obtain an ideal recombinant C-terminal fragment of the merozoite surface protein of Plasmodium falciparum in the Pichia pastoris expression system, the major surface protein-1 19(MSP-119) gene sequence bearing the 6-his gene was inserted into expression vector pPIC9k and the target gene was transformed to the susceptible yeast cells GSll5 by using electroporation. The multiple inserts were screened and the successfully expressed MSP-119 protein with the relative molecular weight of 12kDa in the supernatants of cell cultures could be detected by SDS-PAGE. Meanwhile, Western blot analysis also demonstrated that this protein reacted with mouse anti-MSP-119 monoclonal antibody, and the expression level of MSP-119 was more than 1.0 g/L. It is concluded that this recombinant protein expressed in the Pichia pastoris expression system resembles the native proteins existed.
出处 《中国人兽共患病杂志》 CSCD 北大核心 2005年第12期1047-1051,共5页 Chinese Journal of Zoonoses
基金 This work was supported by Foundation of Qingdao Science and Technology Commission(No.2001KNS-2E-27.2)
关键词 疟原虫 恶性 MSP1 疟疾疫苗 毕赤氏酵母 表达 Plasmodium falciparum MSP-1 malaria vaccine Pichia pastoris expressio
  • 相关文献

参考文献21

  • 1Taylor DW, Zhou A, Marsillio LE,et al.Antibodies that inhibit binding of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate A and to the C terminus of merozoite surface protein 1 correlate with reduced placental malaria in Cameroonian women[J].Infect Immun,2004,72(3):1603.
  • 2Hirunpetcharat C, Vukovic P, Liu XQ,et al.Absolute requirement for an active immune response involving B cells and Th cells in immunity to Plasmodium yoelii passively acquired with antibodies to the 19-kDa carboxyl-terminal fragment of merozoite surface protein-1[J].J Immunol,1999,162(12):7309.
  • 3Singh S, Kennedy MC, Long CA, et al.Biochemical and immunological characterization of bacterially expressed and refolded Plasmodium falciparum 42-kilodalton C-terminal merozoite surface protein 1[J].Infect Immun,2003 71(12):6766.
  • 4Kawabata Y, Udono H, Honma K,et al .Merozoite surface protein 1-specific immune response is protective against exoerythrocytic forms of Plasmodium yoelii[J].Infect Immun,2002,70(11):6075.
  • 5Egan AF, Blackman MJ, and Kaslow DC. Vaccine efficacy of recombinant Plasmodium falciparum merozoite surface protein 1 in malaria-naive,-exposed,and/or -rechallenged Aotus vociferans monkeys[J]. Infect Immun ,2000,68(3):1418.
  • 6John CC, O'Donnell RA, Sumba PO, et al.Evidence that invasion-inhibitory Antibodies Specific for the 19-kDa Fragment of Merozoite Surface Protein-1 (MSP-119) Can Play a Protective Role against Blood-Stage Plasmodium falciparum Infection in Individuals in a Malaria Endemic Area of Africa[J].J Immunol, 2004,173(1): 666.
  • 7Fischer R,Drossard J,Emans N, et al . Towards molecular farming in the future,pichia pastoris-based production of single-chain antibody fragments[J]. Biotechnol Appl Biochem, 1999,30 :117.
  • 8Anthony AH. Malaria vaccines[J]. Pro Naa Acad Sci USA,1999,96:1167.
  • 9Cregg JM, Madden KR, Barringer KJ, et al.Functional characterization of the two alcohol oxidase genes from the yeast Pichia pastoris[J].Mol Cell Biol, 1989,9(3):1316.
  • 10Romanos MA,Scorer CA,Clare JJ.Foreign gene expression in yeast[J].Yeast, 1992,8(6):423.

同被引文献34

  • 1张瑾,辛晓芳.疟疾疫苗研究进展[J].国外医学(预防.诊断.治疗用生物制品分册),2005,28(1):27-29. 被引量:1
  • 2李淑梅,李珣,薛采芳,缪军,雷俊川,刘忠湘,王宪锋.恶性疟原虫裂殖子表面蛋白1 DNA与改良痘苗病毒组合疫苗诱导小鼠抗体应答[J].中国寄生虫学与寄生虫病杂志,2005,23(2):93-96. 被引量:3
  • 3周华,孙立新,朱昌亮.疟疾疫苗研究的主要进展[J].国外医学(寄生虫病分册),2005,32(2):72-76. 被引量:1
  • 4王瑞,钱锋,曲莉,潘卫庆.恶性疟原虫融合抗原PfCP-2.9的单克隆抗体制备及功能分析[J].中国寄生虫学与寄生虫病杂志,2006,24(4):247-250. 被引量:1
  • 5WHO. World Malaria Report 2009[EB/OL]. http://www. who. int/malaria/world_malaria_report 2009/en/index. html.
  • 6Glyde DF. Immunity to falctparum and vivax malaria induced by trradiated review of the university of Maryland studies, 1971 - 1975[M]. Bull WHO, 1990.9- 12.
  • 7Ballou WR, Cahill CP. Two decades of commitment to malaria vaccine development : glaxosmithkline biologicals [J]. The American Society of Tropical Medicine and Hygiene, 2007,77(6) : 289- 95.
  • 8Grtchen V. A complex mew vaccine shows promise[J]. Science, 2004,306..587-9.
  • 9Jose AS, Gray D, Heppner JR. Phase 1 Safety and immunogenicity trial of malaria vaccine RTS,S/ASo2A in adults in a hyperendemic region of Western Kenya[J]. Am J Trop Med Hyg, 2006,75 (1):166-70.
  • 10Cevayir C,Ken JI,Anthony WS.Effect of CpG oligodeoxynucleotides on the immunogenicity of Pfs25,a Plasmodium falciparum transmission-blocking vaccine antigen[J].Infect Immu,2004,1:584-8.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部